These findings extend previous research on the role of B10 cell-derived IL-10 in preventing bone loss in periodontitis, by revealing a new immunosuppressive mechanism through PD-L1/PD-1 signalling.[16] These findings provide a novel perspective that complements existing strategies and may inform the development of innovative immunoregulatory therapies for periodontitis. This evidence concerns the gene CD274 and periodontitis.